Last reviewed · How we verify
NCT05184608
Cycling Dual-task in Parkinson's Disease
NA trial testing Cycling exercise in Parkinson Disease in 15 participants. Completed in 31 January 2022.
28 October 2021
Quick facts
| Lead sponsor | University of Vigo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 11 October 2021 |
| Primary completion | 28 October 2021 |
| Estimated completion | 31 January 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Cycling exercise
- Cognitive tasks
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University of Vigo
Who can join
Eligibility, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of Cycling Dual-Task on Cognitive and Physical Function in Parkinson's Disease: A Randomized Double-Blind Pilot Study.
Pereira-Pedro KP, de Oliveira IM, Mollinedo-Cardalda I, Cancela-Carral JM. · · 2022 · cited 11× · PMID 35805505 · DOI 10.3390/ijerph19137847
Verify or expand the search:
- PubMed search for NCT05184608
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cycling exercise
Trials testing the same drug.
- NCT06292624 — Effectiveness of Intermittent Vacuum Therapy Combined with Aerobic Exercise in Individuals with Diabetes Mellitus · NA · active not recruiting
- NCT05961449 — Mechanisms of Exercise-induced Hypoalgesia · NA · completed
- NCT05565300 — Effects of Cycling Dual-task in Parkinson's Disease. · NA · completed
- NCT04098848 — Intradialytic Exercise on the Fatigue, Sleep Disorder, Arterial Stiffness and Endothelial Function in Uremic Patients · NA · completed
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other University of Vigo trials
Trials by the same sponsor.
- NCT07460492 — Plyometric Strength-Endurance Exercise in Breast Cancer · NA · not yet recruiting
- NCT07419412 — Isometric Strength and Joint Mobility Profile in Elite Artistic Swimmers Across Competitive Categories · recruiting
- NCT07143721 — Comparison of the Effect of Different Inspiratory Loads on Diaphragmatic Function in Healthy Individuals · active not recruiting
- NCT06940206 — Multidirectional Isometric Assessment of the Hip · NA · not yet recruiting
- NCT06437314 — Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05184608 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Vigo
- Last refreshed: 25 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05184608.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing